These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2573106)

  • 21. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Neurochemical findings (author's transl)].
    Bürki HR; Sayers AC; Ruch W; Asper H
    Arzneimittelforschung; 1976; 26(6):1094-6. PubMed ID: 989385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine antagonism of D-1 and D-2 dopamine receptor-mediated behaviors.
    Criswell HE; Mueller RA; Breese GA
    Eur J Pharmacol; 1989 Jan; 159(2):141-7. PubMed ID: 2495973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics.
    Dubuc I; Protais P; Colboc O; Costentin J
    Neuropharmacology; 1982 Nov; 21(11):1203-6. PubMed ID: 6129594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of clozapine on the behavioral and electrographic indices of the arrest function of the caudate nucleus in cats].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1978 May; 85(5):541-4. PubMed ID: 566138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurobehavioral evidence for mesolimbic specificity of action by clozapine: studies using electrical intracranial self-stimulation.
    Gardner EL; Seeger TF
    Biol Psychiatry; 1983 Dec; 18(12):1357-62. PubMed ID: 6661466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine: plasma levels and prolactin response.
    Kane JM; Cooper TB; Sachar EJ; Halpern FS; Bailine S
    Psychopharmacology (Berl); 1981; 73(2):184-7. PubMed ID: 6785813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine.
    Ellenbroek BA; Artz MT; Cools AR
    Eur J Pharmacol; 1991 Apr; 196(1):103-8. PubMed ID: 1678712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural indices of the interaction of clozapine with D1 and D2 dopamine receptors.
    Murray AM; Waddington JL
    Br J Pharmacol; 1989 Dec; 98 Suppl():814P. PubMed ID: 2611521
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine: reduction of the initial dopamine turnover increase by repeated treatment.
    Waldmeier PC; Maître L
    Eur J Pharmacol; 1976 Jul; 38(1):197-203. PubMed ID: 954831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats.
    Imperato A; Angelucci L
    Psychopharmacol Bull; 1989; 25(3):383-9. PubMed ID: 2576318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Psychopharmacology (Berl); 1976 Dec; 51(1):15-22. PubMed ID: 13446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus.
    Youngren KD; Inglis FM; Pivirotto PJ; Jedema HP; Bradberry CW; Goldman-Rakic PS; Roth RH; Moghaddam B
    Neuropsychopharmacology; 1999 May; 20(5):403-12. PubMed ID: 10192821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic biology of clozapine: electrophysiological and neuroendocrinological studies.
    Gudelsky GA; Nash JF; Berry SA; Meltzer HY
    Psychopharmacology (Berl); 1989; 99 Suppl():S13-7. PubMed ID: 2682728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison between some biochemical and behavioural effects produced by neuroleptics.
    Fregnan GB; Porta R
    Arzneimittelforschung; 1981; 31(1):70-4. PubMed ID: 6111328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
    Jiang LH; Kasser RJ; Altar CA; Wang RY
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
    Nakamura S; Engel J; Goldstein M
    Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
    [No Abstract]   [Full Text] [Related]  

  • 40. Clozapine.
    Jann MW
    Pharmacotherapy; 1991; 11(3):179-95. PubMed ID: 1677765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.